Dartmouth Health Continuing Education for Professionals Home, Medicine Grand Rounds - How Emerging Science Can Transform Obesity Care, 10/30/2020 8:00:00 AM - 10/30/2023 9:00:00 AM, Dr. Kaplan describes why obesity is a disease resulting from inappropriate regulation of metabolism and a dysfunction of normal fat mass mechanisms. He advocates for algorithmic assessment and treatment on an individual basis, incorporating lifestyle changes, medication, devices and surgery depending on the severity and clinical need.
Presenter
Lee M. Kaplan, MD, PhD
Director, Obesity, Metabolism and Nutrition Institute and the Obesity Medicine and
Nutrition Fellowship Program, Massachusetts General Hospital
Associate Professor of Medicine, Harvard Medical School
Associate Director, Nutrition and Obesity Research at Harvard
President, The Obesity Society
About our Presenter
Dr. Lee Kaplan graduated from Harvard University and received his MD and PhD in molecular biology from the Albert Einstein College of Medicine. He completed an internship and residency in internal medicine and a fellowship in gastroenterology at MGH and HMS and a fellowship in genetics at Brigham and Women’s Hospital. He is a board-certified specialist in Internal Medicine, Gastroenterology and Obesity Medicine. His research focuses on the role of the gastrointestinal tract and gut microbiota in the regulation of energy balance and metabolic function, including the mechanism of action of bariatric and metabolic surgery, as well as the genetic determinants of obesity and its response to therapy.
Learning Outcome(s)
Participants will be able to describe why obesity is a disease that should be addressed in a non-stigmatizing manner, evaluated in a systematic method and treated in accordance with the heterogeneity of the disease.
Disclosure
In accordance with the disclosure policy of Dartmouth-Hitchcock/Geisel School of Medicine at Dartmouth as well as standards set forth by the Accreditation Council on Continuing Medical Education and the Nursing Continuing Education Council standards set forth by the American Nurses Credentialing Center Commission on Accreditation, continuing medical education and nursing education activity director(s), planning committee member(s), speaker(s), author(s) or anyone in a position to control the content have been asked to disclose any financial relationship* they have to a commercial interest (any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on patients). Such disclosure is not intended to suggest or condone bias in any presentation, but is elicited to provide participants with information that might be of potential importance to their evaluation of a given activity.
The following Activity Physician Director(s), planning committee member(s), speaker(s), author(s) or anyone in a position to control the content have reported the following financial interest or relationship* with various companies/organizations. The Activity Director and Planning Committee member roles were resolved by altering the individual’s control over content about the products or services of the commercial interest by the Associate Dean for CME and the Department of Medicine Chair. The speaker role was resolved by validating the activity content through independent peer review by Kelly Kieffer, MD. All potential conflict(s) were resolved.
* Kelly Kieffer, MD ~ her spouse is a consultant for OcculoBio.
* Richard I. Rothstein, MD ~ has research support from Baranova (research grant to Dartmouth-Hitchcock Medical Center) and is on the Scientific Advisory Board for Allurion.
* Lee M. Kaplan, MD, PhD ~ has grant/research support from Novo Nordisk; he is a consultant for Boehringer Ingelheim, Gelesis, GI Dynamics and Johnson & Johnson.
Other planning committee member(s), speaker(s), activity director(s), author(s) or anyone in a position to control the content for this program report no financial interest or relationship* with any company(ies) or organizations whose product may be germane to the content of their presentations.
*A “financial interest or relationship" refers to an equity position, receipt of royalties, consultantship, funding by a research grant, receiving honoraria for educational services elsewhere, or to any other relationship to a company that provides sufficient reason for disclosure, in keeping with the spirit of the stated policy.
Bibliographic Material
See presentation for bibliographic sources to allow for further study.
Presenter
Lee M. Kaplan, MD, PhD
Director, Obesity, Metabolism and Nutrition Institute and the Obesity Medicine and
Nutrition Fellowship Program, Massachusetts General Hospital
Associate Professor of Medicine, Harvard Medical School
Associate Director, Nutrition and Obesity Research at Harvard
President, The Obesity Society
About our Presenter
Dr. Lee Kaplan graduated from Harvard University and received his MD and PhD in molecular biology from the Albert Einstein College of Medicine. He completed an internship and residency in internal medicine and a fellowship in gastroenterology at MGH and HMS and a fellowship in genetics at Brigham and Women’s Hospital. He is a board-certified specialist in Internal Medicine, Gastroenterology and Obesity Medicine. His research focuses on the role of the gastrointestinal tract and gut microbiota in the regulation of energy balance and metabolic function, including the mechanism of action of bariatric and metabolic surgery, as well as the genetic determinants of obesity and its response to therapy.
Learning Outcome(s)
Participants will be able to describe why obesity is a disease that should be addressed in a non-stigmatizing manner, evaluated in a systematic method and treated in accordance with the heterogeneity of the disease.
Disclosure
In accordance with the disclosure policy of Dartmouth-Hitchcock/Geisel School of Medicine at Dartmouth as well as standards set forth by the Accreditation Council on Continuing Medical Education and the Nursing Continuing Education Council standards set forth by the American Nurses Credentialing Center Commission on Accreditation, continuing medical education and nursing education activity director(s), planning committee member(s), speaker(s), author(s) or anyone in a position to control the content have been asked to disclose any financial relationship* they have to a commercial interest (any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on patients). Such disclosure is not intended to suggest or condone bias in any presentation, but is elicited to provide participants with information that might be of potential importance to their evaluation of a given activity.
The following Activity Physician Director(s), planning committee member(s), speaker(s), author(s) or anyone in a position to control the content have reported the following financial interest or relationship* with various companies/organizations. The Activity Director and Planning Committee member roles were resolved by altering the individual’s control over content about the products or services of the commercial interest by the Associate Dean for CME and the Department of Medicine Chair. The speaker role was resolved by validating the activity content through independent peer review by Kelly Kieffer, MD. All potential conflict(s) were resolved.
* Kelly Kieffer, MD ~ her spouse is a consultant for OcculoBio.
* Richard I. Rothstein, MD ~ has research support from Baranova (research grant to Dartmouth-Hitchcock Medical Center) and is on the Scientific Advisory Board for Allurion.
* Lee M. Kaplan, MD, PhD ~ has grant/research support from Novo Nordisk; he is a consultant for Boehringer Ingelheim, Gelesis, GI Dynamics and Johnson & Johnson.
Other planning committee member(s), speaker(s), activity director(s), author(s) or anyone in a position to control the content for this program report no financial interest or relationship* with any company(ies) or organizations whose product may be germane to the content of their presentations.
*A “financial interest or relationship" refers to an equity position, receipt of royalties, consultantship, funding by a research grant, receiving honoraria for educational services elsewhere, or to any other relationship to a company that provides sufficient reason for disclosure, in keeping with the spirit of the stated policy.
Bibliographic Material
See presentation for bibliographic sources to allow for further study.
